ATN Innovation Summit sessions are now on demand.
Every keynote, panel, and fireside chat are now streaming in the video library.
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
Under a new definition of obesity endorsed by the The American Heart Association, 70% of Americans are obese, up from 40% currently.
The AI-powered Simple Life app ditches calorie counting in favor of data-driven coaching, gamification and habit science.
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Rebel Wilson joins Noom as chief wellness ambassador, backing its new free tier that gamifies healthy habits and spotlights microdose GLP-1s.
FuturHealth, a provider of weight-loss solutions including GLP-1s, will offer Apple Fitness+ at no additional cost to its members.
Hims & Hers' Dr. Craig Primack explains why personalized care, not just GLP-1s, is the key to lasting weight loss success.
Syntis Bio has raised $38M to advance its injectable-free, once-daily pill that mimics gastric bypass surgery.
Northwestern researchers developed an open-source algorithm that improves fitness tracker accuracy for people with obesity.
Sign Up to Our Newsletter
